NeuroLab

NeuroLab Therapeutics is a U.S.-based neurotechnology/device company developing neuromodulatory devices for neurological diseases, with an explicitly stated focus on stroke recovery. Publicly available information indicates the company is an early-stage bioscience business rather than a therapeutics developer with a disclosed drug pipeline. The company appears in the North Carolina life sciences directory as a research and development company in the nervous system/device category. Beyond that, little detailed pipeline, management, financing, or partnership information is publicly available from accessible primary sources. Based on the available evidence, NeuroLab Therapeutics should be characterized as a private, early-stage medical device company in neurorehabilitation.